Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-08-07

Clinical Trial Update: To Evaluate Hallux Terbinafine Subungual Gel (HSG) in the Treatment of Onychomycosis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating Hallux terbinafine subungual gel for treating onychomycosis of the toenail.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hallux terbinafine subungual gel (terbinafine)

Snippet

Sponsor: Hallux, Inc. | Conditions: Onychomycosis of Toenail | Phase 2 | Status: UNKNOWN